Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeXtreme Performance LabNew Technology for Assessment and Rehabilitation of Brain Trauma in Athletes

New Technology for Assessment and Rehabilitation of Brain Trauma in Athletes

Xtreme Performance Lab reports their next-generation technology targets diminished function and network activity caused by concussions and other brain trauma while reducing the potential for future injury

Between 1.7 and 3 million sports and recreation-related concussions happen each year, 300,000 of which are football-related, according to the statistics collected by the UPMC Sports Medicine Concussion Program.  More startling is that according to this data, five out of 10 concussions go unreported or undetected. While many collegiate and professional teams have standardized tests in place, performing baseline tests at the start of the season and implementing others during practice and game situations, these tests don’t do enough to fully identify the scope of injuries and lower the likelihood of future injuries.

Enter Xtreme Performance Lab (XPL), the next generation of sports performance improvement technology. The company recently launched its neuro-physical based athlete training services, and today adds Injury Assessment and Recovery (IAR) via its exclusive NeuroPod PRO™ service delivery platform.

Using advanced brain mapping and analysis software, XPL technology can compare an athlete’s brain activity against prior baseline measurements to look for signs of new brain trauma, concussions, and traumatic brain injury (TBI). Not only can this technology detect an issue, but it can also indicate the location and relative severity of the trauma. This vital information can be shared with medical staff to target recovery protocols and greatly improve treatment outcomes.

“XPL’s advanced brain mapping and qEEG technology is essential for baseline testing, accurate symptom identification, individualized treatment plans and quantifiable measurements regarding overall brain function,” states Michael Mark Psy.D., J.D., BCN, Director of Science and Technology at Xtreme Performance Lab. “It provides us the ability to measure network dynamics that are simply ‘invisible’ to current diagnostic tools. We can now measure where the generators are in the brain that produce patterns that are significantly correlated with the severity of traumatic brain injury. This provides anatomical information about the regions in the brain that are deviant from baseline, enabling us to create recovery training protocols that target specific brain regions, symptoms and neural networks for improvement.”

Utilizing a patent-pending combination of industry-proven biofeedback and neurofeedback techniques, combined with the latest in real-time, 3-dimensional brain monitoring and imaging software, XPL’s NeuroPod PRO delivers the next generation of mental training and assessment services directly to athletes. Services include a comprehensive Performance Capabilities Assessment (like a ‘combine for the mind’), mental performance ZONE training sessions, ‘Game Day’ prep and recovery sessions, as well as the IAR protocols.

“Our goal at XPL has always been to enable athletes to be at their very best, which includes a focus on their safety and well-being,” states David A. Clarke, founder, and CEO of Xtreme Performance Lab. “Whatever the reason, too many athletes are continuing to play with brain trauma. This is a significant cause of further injury. XPL’s next-generation technology greatly improves trauma assessments leading to highly effective individualized recovery protocols. Athletes are now able to get back to optimal performance sooner, and at much less risk of future injury.”


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy